Found 7 matching trials
CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT PHASE1 The purpose of this clinical trial is to examine safety and toxicity of CD4...
Show More Location
University Children's Hospital University Clinic Tuebingen
Learn More & Join Trial
Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT PHASE1 HSCT from an allogeneic donor is the standard therapy for high-risk hematop...
Show More Location
Federal Research Center for pediatric hematology, oncology and immunology
Learn More & Join Trial
Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia NA CAR-T therapy has evolved as a pivotal treatment for relapsed/refractory (R...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC PHASE1 To assess safety of prophylactic escaladed dose of T naïve depleted (CD45RA...
Show More Learn More & Join Trial
Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant PHASE1 Allogeneic stem cell transplantation offers the hope of cure for a wide var...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID) PHASE1 Infants with severe combined immunodeficiency (SCID) have a profound decrea...
Show More Status
Active Not Recruiting
Location
St. Jude Children's Research Hospital
Learn More & Join Trial
CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation PHASE1 The goal of this clinical trial is to learn whether giving patients special...
Show More Learn More & Join Trial